Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA
Clinical trial NCT05354765 · RECRUITING
Trial details
- NCT number
- NCT05354765
- Sponsor
- Institut Curie
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2027-09-03
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.